These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 10221113)

  • 21. Treatment of malignant non-Hodgkin's lymphoma in elderly patients.
    Michiels JJ
    Neth J Med; 1988 Feb; 32(1-2):50-1. PubMed ID: 3347326
    [No Abstract]   [Full Text] [Related]  

  • 22. [Biweekly CHOP-E chemotherapy for aggressive non-Hodgkin's lymphoma].
    Hayashi T; Takahashi T; Mihara M; Shimizu H; Tsukuda H; Kobayashi T; Adachi M; Hinoda Y; Aoki S; Mori M; Tsujisaki M; Imai K
    Gan To Kagaku Ryoho; 1997 May; 24(7):889-91. PubMed ID: 9170532
    [No Abstract]   [Full Text] [Related]  

  • 23. The therapeutic use of rituximab in non-Hodgkin's lymphoma.
    Marcus R; Hagenbeek A
    Eur J Haematol Suppl; 2007 Jan; (67):5-14. PubMed ID: 17206982
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk and timing of hospitalization for febrile neutropenia in patients receiving CHOP, CHOP-R, or CNOP chemotherapy for intermediate-grade non-Hodgkin lymphoma.
    Lyman GH; Delgado DJ
    Cancer; 2003 Dec; 98(11):2402-9. PubMed ID: 14635075
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Self-reported quality of life in elderly patients with aggressive non-Hodgkin's lymphoma treated with CHOP chemotherapy.
    Doorduijn J; Buijt I; Holt B; Steijaert M; Uyl-de Groot C; Sonneveld P
    Eur J Haematol; 2005 Aug; 75(2):116-23. PubMed ID: 16000127
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intensive sequential chemotherapy with hematopoietic growth factor support for non-Hodgkin lymphoma in patients infected with the human immunodeficiency virus.
    Costello RT; Zerazhi H; Charbonnier A; de Colella JM; Alzieu C; Poizot-Martin I; Cohen R; Bardou VJ; Xerri L; Olive D; Nezri M; Lepeu G; Gastaut JA
    Cancer; 2004 Feb; 100(4):667-76. PubMed ID: 14770420
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Comparison of effectiveness of adriamycin and epirubicin administered in the CHOP protocol to patients with malignant non-hodgkin's lymphoma].
    Rolski J; Koralewski P; Pawlicki M
    Wiad Lek; 1993 May; 46(9-10):356-9. PubMed ID: 8236992
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combined chemotherapy with carmustine, doxorubicin, etoposide, vincristine, and cyclophosphamide plus mitoxantrone, cytarabine and methotrexate with citrovorum factor for the treatment of aggressive non-Hodgkin lymphoma: a long-term follow-up study.
    Rigacci L; Carrai V; Nassi L; Alterini R; Longo G; Bernardi F; Bosi A
    Cancer; 2005 Mar; 103(5):970-7. PubMed ID: 15666323
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intermediate dose of nonpegylated liposomal doxorubicin combination (R-CMyOP) as first line chemotherapy for frail elderly patients with aggressive lymphoma.
    Gimeno E; Sánchez-González B; Alvarez-Larrán A; Pedro C; Abella E; Comín J; Saumell S; García-Pallarols F; Gómez M; Besses C; Salar A
    Leuk Res; 2011 Mar; 35(3):358-62. PubMed ID: 20708263
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Full-dose chemotherapy for non-Hodgkin's lymphoma in the elderly. Dutch Hematology-Oncology in Adults Study Group.
    Sonneveld P; Hop W; Mulder AH; Michiels JJ; Blijham G; van de Lelie J; Raemakers JW; Nieuwenhuis K; van der Heul C
    Semin Hematol; 1994 Apr; 31(2 Suppl 3):9-12. PubMed ID: 8073309
    [No Abstract]   [Full Text] [Related]  

  • 31. [Treatment of non-Hodgkin's lymphoma with CHOP therapy: analysis of lymphocyte subsets and interleukin 2 activity during CHOP therapy].
    Suzuki Y; Yamada H; Saito Y; Nakajima H; Shinozaki T; Isono M; Chikada K; Maeno H; Sawaki S; Yamada K
    Nihon Gan Chiryo Gakkai Shi; 1986 Jul; 21(6):1225-31. PubMed ID: 3491170
    [No Abstract]   [Full Text] [Related]  

  • 32. [Effect of granulocyte colony-stimulating factor after chemotherapy with CHOP in patients with non-Hodgkin's lymphoma and HIV infection].
    Navarro JT; Ribera JM; Gómez-Espuch J; Feliu E
    Med Clin (Barc); 1996 Jun; 107(3):118-9. PubMed ID: 8754503
    [No Abstract]   [Full Text] [Related]  

  • 33. CHOP versus intensive regimens in non-Hodgkin's lymphoma.
    Salloum E; Levin M
    N Engl J Med; 1993 Aug; 329(8):581; author reply 581-2. PubMed ID: 8336764
    [No Abstract]   [Full Text] [Related]  

  • 34. Treatment of intermediate-grade and high-grade non-Hodgkin's lymphoma.
    Machida U; Kami M; Hirai H
    N Engl J Med; 1998 Nov; 339(20):1475-6; author reply 1477. PubMed ID: 9841318
    [No Abstract]   [Full Text] [Related]  

  • 35. [Studies of patients with non-Hodgkin's lymphoma unresponsive to C-MOPP].
    Shirakawa S; Shimizu K; Shinkai K; Kojima H; Maruyama F; Sobue R; Ito N; Imura H; Matsui T; Ino T
    Rinsho Ketsueki; 1988 Jul; 29(7):1025-30. PubMed ID: 3184470
    [No Abstract]   [Full Text] [Related]  

  • 36. [Diagnosis and treatment of non-Hodgkin lymphoma in elderly patients].
    Doorduijn JK; Sonneveld P
    Ned Tijdschr Geneeskd; 1997 Nov; 141(45):2152-7. PubMed ID: 9550794
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Generalized granuloma annulare and non-Hodgkin's lymphoma.
    Bassi A; Scarfi F; Galeone M; Arunachalam M; Difonzo E
    Acta Derm Venereol; 2013 Jul; 93(4):484-5. PubMed ID: 23250047
    [No Abstract]   [Full Text] [Related]  

  • 38. Combination chemotherapy ("MABOP") in advanced refractory lymphocytic lymphoma with unfavorable histology.
    Giustolisi R; Guglielmo P; Di Raimondo F; Milone G; Cacciola E
    Haematologica; 1982 Oct; 67(5):718-24. PubMed ID: 6184271
    [No Abstract]   [Full Text] [Related]  

  • 39. Treatment of elderly patients with intermediate- and high-grade non-Hodgkin's lymphoma: a retrospective population-based study.
    Peters FP; Lalisang RI; Fickers MM; Erdkamp FL; Wils JA; Houben SG; Wals J; Schouten HC
    Ann Hematol; 2001 Mar; 80(3):155-9. PubMed ID: 11320900
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fatal myelofibrosis following fludarabine administration in a patient with indolent lymphoma.
    Palomera L; Azaceta G; Varo MJ; Soria J; Gutierrez M
    Haematologica; 1998 Nov; 83(11):1045-6. PubMed ID: 9864929
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.